PHOTO PROVIDED These cutting-edge devices use UV light to eliminate harmful pathogens.

DANVILLE — Geisinger is deploying advanced ultraviolet (UV) disinfection devices across its hospital campuses, enhancing infection prevention efforts in patient care areas.

These cutting-edge devices use UV light to eliminate harmful pathogens. They improve safety by disinfecting patient rooms following manual cleaning, specifically if the room was occupied by someone with an illness that can be spread.

“Bringing UV disinfection technology into our hospitals is a powerful step forward in protecting our patients,” said Mark Shelly, M.D., medical director of infection prevention. “It’s not just about adding new tools. It’s about strengthening our commitment to safety and quality and doing everything we can to prevent hospital-acquired infections. A visibly clean surface is just the beginning. Because germs are invisible, they’re susceptible to UV light. This technology helps us take another meaningful step toward becoming a high-reliability organization, where safety is at the center of everything we do.”

How the technology works

— Fast and effective: Disinfects rooms in just 12 to 30 minutes, depending on room size.

— Smart technology: Tracks usage and automatically adjusts UV light levels to ensure thorough disinfection, even in shadowed or hard-to-reach areas.

— Safe and secure: Operated exclusively by trained Environmental Services technicians. Rooms are clearly marked during use to ensure safety.

— Targeted use: Used in patient rooms previously occupied by someone with an illness that can be spread.

Tested, trusted and now everywhere

Following successful trials at Geisinger Medical Center and Geisinger Wyoming Valley Medical Center, where the devices were integrated without disrupting patient flow, 16 of the devices are now being introduced system wide.

Stopping germs in

their tracks

The UV disinfection devices are effective against a wide range of pathogens, including:

— Clostridioides difficile (C. diff)

— Staphylococcus aureus

— Pseudomonas aeruginosa

— Methicillin-resistant Staphylococcus aureus (MRSA)

— Vancomycin-resistant Enterococcus faecalis (VRE)

— Acinetobacter baumannii

— Klebsiella pneumoniae

— Influenza A

— Norovirus

About Geisinger

Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates $10 billion in annual revenues across 126 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,700 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $15 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on Facebook, Instagram, LinkedIn and X.